ArticleOncoTargets and therapy2020

Autologous Cytokine-Induced Killer Cell Immunotherapy for Patients with High-Risk Diffuse Large B Cell Lymphoma After the First Complete Remission.

Min Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.